✦ LIBER ✦

O1-01-01: Caffeine: Evidence for protection against, and treatment for, Alzheimer’s disease by direct suppression of disease pathogenesis

✍ Scribed by Gary W. Arendash; Kavon Rezai-Zadeh; Chuanhai Cao; Malgorzata Mamcarz; Alexander Dickson; William Schleif; Melissa Runfeldt; Xiaoyang Lin; Jennifer Cracchiolo; Daniel Shippy; Ashok Raj; Jun Tan; Huntington Potter

Book ID: 118463442
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 145 KB
Volume: 3
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2007.04.355

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Protection against developmental retarda

Protection against developmental retardation in apolipoprotein E-deficient mice by a fatty neuropeptide: Implications for early treatment of Alzheimer's disease

✍ Gozes, Illana ;Bachar, Michal ;Bardea, Amos ;Davidson, Ariane ;Rubinraut, Sarah 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 2 views

Stearyl-Nle 17 -VIP (SNV) is a novel milestones, with peptide-treated animals developing agonist of vasoactive intestinal peptide (VIP) exhibas fast as control animals and exhibiting improved iting a 100-fold greater potency than the parent molecule and specificity for a receptor associated with neu

Protection against amyloid beta-peptide

Protection against amyloid beta-peptide (1–42)-induced loss of phospholipid asymmetry in synaptosomal membranes by tricyclodecan-9-xanthogenate (D609) and ferulic acid ethyl ester: Implications for Alzheimer's disease

✍ Hafiz Mohmmad Abdul; D. Allan Butterfield 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 165 KB